Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Metastatic
Natasha Rekhtman MD PhD
natasharekhtman
Is there such a thing as PRIMARY PULMONARY MELANOMA?? What if melanoma presents exclusively in the lung? No evidence of skin, mucosal or ocular primary? Not even after exhaustive evaluation?
Read more
Sanjee Baksh, PhD
S__Baksh
2020 has been terrible for many reasons, but there have been some really cool metabolism papers this year. In no particular order, here are my top 10 (because I couldn't
Read more
Paul Williams
PaulNWilliamz
*How to round with Paul Williams*Tips for medical students, interns, and the curious - a threadJust in case this might be helpful. Your mileage may vary with other attendings, who
Read more
Roberto Pestana, MD
PestanaRC
Interesting report on targetable fusions in KRAS WT #PancreaticCancer. I often find that therapeutic nihilism prevents sequencing of these patients, but recent data supports that, although rare, actionable alterations are
Read more
Zoé
ztsamudzi
I appreciate the thrust of this piece about how analogies about white supremacy/nationalism obscure the problem at hand, but it doesn't consider the issues of relying on disease pathology to
Read more
Rita Faria
RitaINdeFaria
I'm now logging into #ISPOREurope live session IP3: The Meaning of Cure – the Search for What? with @NRLatimer, @BettinaRyll, and K. Jack Ishak and Ágnes Benedict from @evideraglobal https://ispor-europe2020.secure-platform.com/a/gal
Read more
Chris Jones
CAJonesMD
@DukePallCare SUCCESS! Journal Club Time Machine: Speed Dating with the Classics. Format - everyone in attendance (MS2-Attending) teaches a classic article for 4 minutes, it is put in context by
Read more
Amit Kulkarni
AmitKulkarniMD
#FDA recently approved #pembrolizumab- a tissue agnostic indication in metastatic tumors with high #TMB (>10 mut/MB) using Foundation One Dx companion diagnostic test. I want to share a tweetorial on
Read more
Sri Krishna
tellkrish
With @franklowery our new study on attributes of T cells that contribute to successful cell therapy in cancer patients in @ScienceMagazine today w/ colleagues @slgoff_SB, @NCI_CCR_SB @theNCI a TL;DR thread
Read more
Bishal Gyawali
oncology_bg
This thread is going to be a collection of all my #globaloncology papers, primarily for my own reference to bookmark for quick access but also, just in case, it is
Read more
Thee Lady Doctor Says تقول الطبيبة
LadyDoctorSays
If you have a tattoo, you should have no qualms about getting the COVID vaccine. Walk with me on a journey... 1/ A 2015 Harris poll & 2016 McCrindle poll
Read more
Ariella Hanker
AriellaHanker
Tremendous effort from Dr. Kyung-min Lee identifying PRR11 as the gene in the 17q23 amplicon that promotes #antiestrogen resistance in #breastcancer, via activation of #PI3K. @NatureComms Thread https://www.nature.com/articles/s41467-020-19
Read more
Absurdistwords
absurdistwords
Get it now?https://twitter.com/absurdistwords/status/975092474858344448 The same people who stormed the capitol are the same people who gleefully support police violence against Black and Brown people.The same people who terrorize churches
Read more
Andy Flies
WildImmunity
Happy to announce that our new paper that developed colorful system to understand immune evasion by transmissible cancers has been published in @ScienceAdvances https://advances.sciencemag.org/content/6/27/eaba5031Here’s the story behind
Read more
Imo 🇪🇺⭐️ Locke 💙
ImogenLocke
It’s World Cancer Day today so let’s celebrate the achievements of the UK radiotherapy community. Don’t forget to RT and add that glaring omission! @RCRadiologists @SCoRMembers @ActionRTherapy @CR_UK Practice changing
Read more
Tristan D Rutland
TristanRutland7
Anterior mediastinum, Female adult#pulmpath #surgpath #pathtwitter Question:Based in the initial images, what is your first impression? Immunohistochemistry:PAX8 CD117 P40 Based on further IHC, what do you now favour?*carcinoma CD5 More
Read more
‹
1
2
3
4
5
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree